March 3, 2020 / 12:24 PM / a month ago

BRIEF-Antares Pharma Reports Q4 Earnings Per Share $0.03

March 3 (Reuters) - Antares Pharma Inc:

* ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2019 OPERATING AND FINANCIAL RESULTS

* Q4 EARNINGS PER SHARE $0.03

* Q4 REVENUE $37.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $32.3 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $0.00 — REFINITIV IBES DATA

* SEES FY 2020 REVENUE $135 MILLION TO $155 MILLION

* ANTARES PHARMA - AT DEC 31, 2019, CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $45.7 MILLION COMPARED TO $27.9 MILLION AT DECEMBER 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below